CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 49.06
-0.84 (-1.68%)
Aug 19, 2025, 11:44 AM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 17.21 billion as of August 18, 2025. Its market cap has increased by 134.20% in one year.
Market Cap
17.21B
Enterprise Value
16.03B
Revenue
931.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.06
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 17.21B, an increase of 127.32%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 17.19B | 48.11% |
| Dec 31, 2024 | 11.61B | -7.06% |
| Dec 29, 2023 | 12.49B | -54.89% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | 74.41B | 466.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |